BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 7683331)

  • 1. Autoantibodies to myelin basic protein within multiple sclerosis central nervous system tissue.
    Warren KG; Catz I
    J Neurol Sci; 1993 Apr; 115(2):169-76. PubMed ID: 7683331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased synthetic peptide specificity of tissue-CSF bound anti-MBP in multiple sclerosis.
    Warren KG; Catz I
    J Neuroimmunol; 1993 Mar; 43(1-2):87-96. PubMed ID: 7681451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An extensive search for autoantibodies to myelin basic protein in cerebrospinal fluid of non-multiple-sclerosis patients: implications for the pathogenesis of multiple sclerosis.
    Warren KG; Catz I
    Eur Neurol; 1999; 42(2):95-104. PubMed ID: 10473981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-myelin basic protein and anti-proteolipid protein specific forms of multiple sclerosis.
    Warren KG; Catz I; Johnson E; Mielke B
    Ann Neurol; 1994 Mar; 35(3):280-9. PubMed ID: 7510098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of autoantibodies to myelin basic protein by antigen specific affinity chromatography from cerebrospinal fluid IgG of multiple sclerosis patients. Immunoreactivity studies with human myelin basic protein.
    Warren KG; Catz I
    J Neurol Sci; 1991 May; 103(1):90-6. PubMed ID: 1713953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal synthesis of autoantibodies to myelin basic protein in multiple sclerosis.
    Catz I; Warren KG
    Can J Neurol Sci; 1986 Feb; 13(1):21-4. PubMed ID: 2420428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A myelin basic protein antibody cascade in purified IgG from cerebrospinal fluid of multiple sclerosis patients.
    Warren KG; Catz I
    J Neurol Sci; 1990 Apr; 96(1):19-27. PubMed ID: 1693669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative frequency of autoantibodies to myelin basic protein and proteolipid protein in optic neuritis and multiple sclerosis cerebrospinal fluid.
    Warren KG; Catz I
    J Neurol Sci; 1994 Jan; 121(1):66-73. PubMed ID: 7510787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic peptide specificity of anti-myelin basic protein from multiple sclerosis cerebrospinal fluid.
    Warren KG; Catz I
    J Neuroimmunol; 1992 Jul; 39(1-2):81-9. PubMed ID: 1377712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optic neuritis anti-myelin basic protein synthetic peptide specificity.
    Warren KG; Catz I; Shutt K
    J Neurol Sci; 1992 May; 109(1):88-95. PubMed ID: 1381412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralization of anti-myelin basic protein by cerebrospinal fluid of multiple sclerosis patients in clinical remission.
    Warren KG; Catz I
    J Neurol Sci; 1988 Dec; 88(1-3):185-94. PubMed ID: 2465390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of brain-specific autoantibodies to myelin oligodendrocyte glycoprotein, S100beta and myelin basic protein in patients with Devic's neuromyelitis optica.
    Haase CG; Schmidt S
    Neurosci Lett; 2001 Jul; 307(2):131-3. PubMed ID: 11427318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSF antibodies to myelin basic protein and to myelin-associated glycoprotein in multiple sclerosis. Evidence of the intrathecal production of antibodies.
    Wajgt A; Górny M
    Acta Neurol Scand; 1983 Nov; 68(5):337-43. PubMed ID: 6198864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of primary antibodies of the myelin basic protein antibody cascade from multiple sclerosis patients. Immunoreactivity studies with homologous and heterologous antigens.
    Warren KG; Catz I
    Clin Invest Med; 1992 Feb; 15(1):18-29. PubMed ID: 1373999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoreactive T and B cells in nervous system diseases.
    Sun JB
    Acta Neurol Scand Suppl; 1993; 142():1-56. PubMed ID: 8382894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody to myelin basic protein in extracts of multiple sclerosis brain.
    Bernard CC; Randell VB; Horvath LB; Carnegie PR; Mackay IR
    Immunology; 1981 Jul; 43(3):447-57. PubMed ID: 6166547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelin basic protein-reactive autoantibodies in the serum and cerebrospinal fluid of multiple sclerosis patients are characterized by low-affinity interactions.
    O'Connor KC; Chitnis T; Griffin DE; Piyasirisilp S; Bar-Or A; Khoury S; Wucherpfennig KW; Hafler DA
    J Neuroimmunol; 2003 Mar; 136(1-2):140-8. PubMed ID: 12620653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathecal synthesis of anti-myelin basic protein IgG in HIV-1+ patients.
    Maimone D; Annunziata P; Cioni C; Leonardi A; Guazzi GC
    Acta Neurol Scand; 1994 Oct; 90(4):285-92. PubMed ID: 7530889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of cerebrospinal fluid anti-myelin basic protein in patients with multiple sclerosis.
    Warren KG; Catz I
    Ann Neurol; 1986 Jul; 20(1):20-5. PubMed ID: 2427010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid autoantibodies to myelin basic protein in multiple sclerosis patients. Detection during first exacerbations and kinetics of acute relapses and subsequent convalescent phases.
    Warren KG; Catz I
    J Neurol Sci; 1989 Jun; 91(1-2):143-51. PubMed ID: 2473170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.